Michael S. Ascher

10.9k total citations · 6 hit papers
76 papers, 7.3k citations indexed

About

Michael S. Ascher is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Michael S. Ascher has authored 76 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Infectious Diseases, 19 papers in Virology and 11 papers in Molecular Biology. Recurrent topics in Michael S. Ascher's work include HIV Research and Treatment (16 papers), HIV/AIDS Research and Interventions (15 papers) and Viral Infections and Vectors (12 papers). Michael S. Ascher is often cited by papers focused on HIV Research and Treatment (16 papers), HIV/AIDS Research and Interventions (15 papers) and Viral Infections and Vectors (12 papers). Michael S. Ascher collaborates with scholars based in United States, United Kingdom and Canada. Michael S. Ascher's co-authors include Michael T. Osterholm, Trish M. Perl, Kevin Tonat, Jerome Hauer, Gerald Parker, Edward M. Eitzen, Thomas V. Inglesby, John G. Bartlett, Philip K. Russell and Joseph E. McDade and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Michael S. Ascher

76 papers receiving 6.9k citations

Hit Papers

Botulinum Toxin as a Biological Weapon 1999 2026 2008 2017 2001 1999 2001 2002 2000 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Botulinum Toxin as a Biological Weapon
    2001 1.3k citations Robert Schechter, Thomas V. Inglesby et al. JAMA profile →
  2. Smallpox as a Biological Weapon
    1999 1.2k citations Thomas V. Inglesby, John G. Bartlett et al. JAMA profile →
  3. Tularemia as a Biological Weapon
    2001 1.0k citations David T. Dennis, Thomas V. Inglesby et al. JAMA profile →
  4. Anthrax as a Biological Weapon, 2002
    2002 729 citations Thomas V. Inglesby, Tara O’Toole et al. JAMA profile →
  5. Plague as a Biological Weapon
    2000 708 citations Thomas V. Inglesby, David T. Dennis et al. JAMA profile →
  6. Anthrax as a Biological Weapon
    1999 625 citations Thomas V. Inglesby, Donald A. Henderson et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael S. Ascher United States 29 4.1k 2.3k 2.0k 1.5k 930 76 7.3k
Edward M. Eitzen United States 19 4.5k 1.1× 2.4k 1.0× 1.4k 0.7× 1.1k 0.7× 933 1.0× 30 6.6k
Thomas V. Inglesby United States 29 4.4k 1.1× 2.3k 1.0× 1.6k 0.8× 1.1k 0.7× 960 1.0× 80 7.6k
Jerome Hauer United States 12 4.0k 1.0× 2.2k 1.0× 1.1k 0.6× 968 0.6× 934 1.0× 19 6.0k
Kevin Tonat United States 11 4.1k 1.0× 2.2k 1.0× 1.2k 0.6× 981 0.7× 932 1.0× 12 5.9k
Gerald Parker United States 10 4.0k 1.0× 2.3k 1.0× 1.1k 0.6× 969 0.6× 961 1.0× 14 5.9k
Donald A. Henderson United States 21 2.6k 0.6× 1.3k 0.6× 1.1k 0.5× 754 0.5× 960 1.0× 51 5.3k
Tara O’Toole United States 27 3.2k 0.8× 1.3k 0.6× 1.2k 0.6× 848 0.6× 913 1.0× 53 5.6k
Philip K. Russell United States 43 3.5k 0.9× 2.1k 0.9× 3.4k 1.7× 1.1k 0.7× 938 1.0× 111 9.2k
Scott R. Lillibridge United States 19 1.9k 0.5× 946 0.4× 749 0.4× 442 0.3× 922 1.0× 35 4.0k
Anne D. Fine United States 12 1.9k 0.5× 1.3k 0.6× 727 0.4× 439 0.3× 920 1.0× 18 3.7k

Countries citing papers authored by Michael S. Ascher

Since Specialization
Citations

This map shows the geographic impact of Michael S. Ascher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Ascher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Ascher more than expected).

Fields of papers citing papers by Michael S. Ascher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael S. Ascher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Ascher. The network helps show where Michael S. Ascher may publish in the future.

Co-authorship network of co-authors of Michael S. Ascher

This figure shows the co-authorship network connecting the top 25 collaborators of Michael S. Ascher. A scholar is included among the top collaborators of Michael S. Ascher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael S. Ascher. Michael S. Ascher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zeng, Daniel, Hsinchun Chen, Catherine Larson, et al.. (2004). Towards a national infectious disease information infrastructure: a case study in West Nile virus and botulism. International Conference on Digital Government Research. 126. 9 indexed citations
2.
Zeng, Daniel, Hsinchun Chen, Catherine Larson, et al.. (2004). Sharing and visualizing infectious disease datasets using the WNV-BOT portal system. International Conference on Digital Government Research. 115. 2 indexed citations
3.
Moon, Harley W., Michael S. Ascher, R. James Cook, et al.. (2003). US Agriculture Is Vulnerable to Bioterrorism. Journal of Veterinary Medical Education. 30(2). 96–104. 8 indexed citations
4.
Upchurch, Gilbert R., Mary Proctor, Peter K. Henke, et al.. (2003). Predictors of severe morbidity and death after elective abdominal aortic aneurysmectomy in patients with chronic obstructive pulmonary disease. Journal of Vascular Surgery. 37(3). 594–599. 42 indexed citations
5.
Arnon, Stephen S., Robert Schechter, Thomas V. Inglesby, et al.. (2001). Botulinum toxin as a biological weapon. JAMA. 285(8). 95 indexed citations
6.
Cone, Lawrence A., Debora Williams‐Herman, Jessica Rowland, et al.. (2000). Fatal illnesses associated with a new world arenavirus - California, 1999-2000. JAMA. 284(10). 1237–1238. 30 indexed citations
7.
Inglesby, Thomas V., David T. Dennis, Donald A. Henderson, et al.. (2000). Plague as a Biological Weapon. JAMA. 283(17). 2281–2281. 708 indexed citations breakdown →
8.
Fessel, W. Jeffrey, John F. Krowka, Haynes W. Sheppard, et al.. (2000). Dissociation of Immunologic and Virologic Responses to Highly Active Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 23(4). 314–320. 20 indexed citations
9.
Inglesby, Thomas V., John G. Bartlett, Michael S. Ascher, et al.. (1999). Smallpox as a Biological Weapon. JAMA. 281(22). 2127–2127. 1179 indexed citations breakdown →
10.
Anderson, Russell W., Michael S. Ascher, & Haynes W. Sheppard. (1998). Direct HIV Cytopathicity Cannot Account for CD4 Decline in AIDS in the Presence of Homeostasis: A Worst-Case Dynamic Analysis. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 17(3). 245–252. 63 indexed citations
11.
Sheppard, Haynes W., et al.. (1996). The lack of association of Marijuana and other recreational drugs with progression to AIDS in the San Francisco men's health study. Annals of Epidemiology. 6(4). 283–289. 29 indexed citations
12.
Hjelle, Brian, Frederick Koster, Michele T. Jay, et al.. (1996). Epidemiologic Linkage of Rodent and Human Hantavirus Genomic Sequences in Case Investigations of Hantavirus Pulmonary Syndrome. The Journal of Infectious Diseases. 173(4). 781–786. 32 indexed citations
13.
Tappero, Jordan W., Joseph Bresee, C. J. Peters, et al.. (1994). Hantavirus Pulmonary Syndrome in California: Report of Two Cases and Investigation. Clinical Infectious Diseases. 19(6). 1105–1109. 12 indexed citations
14.
Sheppard, Haynes W. & Michael S. Ascher. (1992). THE NATURAL HISTORY AND PATHOGENESIS OF HIV INFECTION. Annual Review of Microbiology. 46(1). 533–564. 28 indexed citations
15.
Benenson, Abram S., et al.. (1992). Prevalence of Human T cell Lymphotropic Virus Types 1 and 2 (HTLV-1/2) in Selected Tijuana Subpopulations. American Journal of Tropical Medicine and Hygiene. 47(2). 127–132. 7 indexed citations
16.
Rhee, Kenneth J., Timothy E. Albertson, Kenneth W. Kizer, et al.. (1992). A comparison of HIV-1, HBV, and HTLV-I/II seroprevalence rates of injured patients admitted through California emergency departments. Annals of Emergency Medicine. 21(4). 397–401. 11 indexed citations
17.
McRae, Brian J., Michael S. Ascher, F. de Wolf, et al.. (1991). Immune Response to HIV p24 Core Protein During the Early Phases of Human Immunodeficiency Virus Infection. AIDS Research and Human Retroviruses. 7(8). 637–643. 21 indexed citations
18.
Rhee, Kenneth J., Timothy E. Albertson, Kenneth W. Kizer, Michael Hughes, & Michael S. Ascher. (1991). The HIV-1 seroprevalence rate of injured patients admitted through California emergency departments. Annals of Emergency Medicine. 20(9). 969–972. 25 indexed citations
19.
Ascher, Michael S., et al.. (1985). Q Fever and Experimental Sheep. Infection Control. 6(3). 122–123. 9 indexed citations
20.
Ascher, Michael S., et al.. (1976). Transfer factor : basic properties and clinical applications : proceedings of the Second International Workshop on Basic Properties and Clinical Applications of Transfer Factor, held at the United States Army Medical Research Institute of Infectious Diseases, October 5-8, 1975. Academic Press eBooks. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edward M. Eitzen Breakdown of academic impact, for papers by Thomas V. Inglesby Breakdown of academic impact, for papers by Jerome Hauer Breakdown of academic impact, for papers by Kevin Tonat Breakdown of academic impact, for papers by Gerald Parker Breakdown of academic impact, for papers by Donald A. Henderson Breakdown of academic impact, for papers by Tara O’Toole Breakdown of academic impact, for papers by Philip K. Russell Breakdown of academic impact, for papers by Scott R. Lillibridge Breakdown of academic impact, for papers by Anne D. Fine
Rankless by CCL
2026